Correlation Between PTC Therapeutics and Terns Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on PTC Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Terns Pharmaceuticals.

Diversification Opportunities for PTC Therapeutics and Terns Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between PTC and Terns is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Terns Pharmaceuticals go up and down completely randomly.

Pair Corralation between PTC Therapeutics and Terns Pharmaceuticals

Given the investment horizon of 90 days PTC Therapeutics is expected to generate 0.93 times more return on investment than Terns Pharmaceuticals. However, PTC Therapeutics is 1.08 times less risky than Terns Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest  4,248  in PTC Therapeutics on August 24, 2024 and sell it today you would earn a total of  41.00  from holding PTC Therapeutics or generate 0.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PTC Therapeutics  vs.  Terns Pharmaceuticals

 Performance 
       Timeline  
PTC Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

PTC Therapeutics and Terns Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PTC Therapeutics and Terns Pharmaceuticals

The main advantage of trading using opposite PTC Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.
The idea behind PTC Therapeutics and Terns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities